DCF — OLH-SHREVEPORT-ST. MARY MEDICAL CTR
Enterprise Value: $-80.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-80.6M
Enterprise Value
$-27.0M
PV of Cash Flows
$-53.6M
PV of Terminal Value
$-86.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $93.8M | $-4.2M | -5.0% | $-8.2M | $-7.5M |
| Year 2 | $96.7M | $-3.4M | -4.0% | $-7.5M | $-6.2M |
| Year 3 | $99.6M | $-2.5M | -3.0% | $-6.7M | $-5.0M |
| Year 4 | $102.6M | $-2.1M | -2.0% | $-6.4M | $-4.4M |
| Year 5 | $105.6M | $-1.8M | -2.0% | $-6.3M | $-3.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-80.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$91.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000004389994274
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5